1

Belite Bio

#5953

Rank

$334.07M

MarketCap US

US United States

Country

Summary
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

History

Belite Bio was founded in 2020 with a vision to deliver novel and meaningful breakthroughs in the area of biotechnology. The company has grown from a small startup to a leading biotechnology company, with a mission of improving outcomes for patients and creating innovative solutions for unmet medical needs.


Mission
Belite Bio is committed to developing therapeutic treatments for complex diseases that improve people’s lives.

Vision
Belite Bio’s vision is to be a leading biotechnology company that is determined to find and bring innovative solutions to the world.

Key Team

Ms. Ching-Chen Chiu M.Sc. (VP of Clinical Operations)


Recognition and Awards
Belite Bio is a proud recipient of the 2020 Science and Technology Innovation Award from the National Institutes of Health and the 2020 Technology Award from the Society of Chemical Technology.

References
Belite Bio
Leadership team

Dr. Yu-Hsin Lin M.B.A., Ph.D. (Chairman of Directors & CEO)

Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A. (CFO & Director)

Dr. Nathan L. Mata Ph.D. (Chief Scientific Officer)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Headquarters
San Diego, California, United States
Established
2018
Company Registration
SEC CIK number: 0001889109
Traded as
BLTE
Social Media
About

Businessabc provides a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with
Logo

Copyright 2023 © Businessabc powered by ztudium